TrialLancet (London, England)2017

Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial.

Eric Rullier et al.PubMed ↗Publisher ↗

No numbers read from the abstract.